Keywords
Last Name
Institution

Myron E. Schwartz

TitlePROFESSOR
InstitutionMount Sinai
DepartmentSurgical Oncology
Address5 East 98th Street
12th Floor, Box 1104
New York NY 10029
Phone212-659-8084
Fax646-537-9238

     Bibliographic 
     selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Kolev V, Pereira EB, Schwartz M, Sarpel U, Roayaie S, Labow D, Momeni M, Chuang L, Dottino P, Rahaman J, Zakashansky K. The role of liver resection at the time of secondary cytoreduction in patients with recurrent ovarian cancer. Int J Gynecol Cancer. 2014 Jan; 24(1):70-4.
      View in: PubMed
    2. Roayaie S, Jibara G, Taouli B, Schwartz M. Resection of hepatocellular carcinoma with macroscopic vascular invasion. Ann Surg Oncol. 2013 Nov; 20(12):3754-60.
      View in: PubMed
    3. Wang Q, Fiel MI, Blank S, Luan W, Kadri H, Kim KW, Manizate F, Rosenblatt AG, Labow DM, Schwartz ME, Hiotis SP. Impact of liver fibrosis on prognosis following liver resection for hepatitis B-associated hepatocellular carcinoma. Br J Cancer. 2013 Aug 6; 109(3):573-81.
      View in: PubMed
    4. Facciuto M, Contreras-Saldivar A, Singh MK, Rocca JP, Taouli B, Oyfe I, LaPointe Rudow D, Gondolesi GE, Schiano TD, Kim-Schluger L, Schwartz ME, Miller CM, Florman S. Right hepatectomy for living donation: role of remnant liver volume in predicting hepatic dysfunction and complications. Surgery. 2013 May; 153(5):619-26.
      View in: PubMed
    5. Roayaie S, Obeidat K, Sposito C, Mariani L, Bhoori S, Pellegrinelli A, Labow D, Llovet JM, Schwartz M, Mazzaferro V. Resection of hepatocellular cancer =2 cm: results from two Western centers. Hepatology. 2013 Apr; 57(4):1426-35.
      View in: PubMed
    6. Sia D, Hoshida Y, Villanueva A, Roayaie S, Ferrer J, Tabak B, Peix J, Sole M, Tovar V, Alsinet C, Cornella H, Klotzle B, Fan JB, Cotsoglou C, Thung SN, Fuster J, Waxman S, Garcia-Valdecasas JC, Bruix J, Schwartz ME, Beroukhim R, Mazzaferro V, Llovet JM. Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes. Gastroenterology. 2013 Apr; 144(4):829-40.
      View in: PubMed
    7. Schwartz ME, Shrager B. Surgical resection for hepatocellular carcinoma in the noncirrhotic: the Western experience. Recent Results Cancer Res. 2013; 190:85-100.
      View in: PubMed
    8. Zhu H, Obeidat K, Ouyang J, Roayaie S, Schwartz ME, Thung SN. Recurrent giant hemangiomas of liver: Report of two rare cases with literature review. World J Gastrointest Surg. 2012 Nov 27; 4(11):262-6.
      View in: PubMed
    9. Wang X, Prakash S, Lu M, Tripodi J, Ye F, Najfeld V, Li Y, Schwartz M, Weinberg R, Roda P, Orazi A, Hoffman R. Spleens of myelofibrosis patients contain malignant hematopoietic stem cells. J Clin Invest. 2012 Nov 1; 122(11):3888-99.
      View in: PubMed
    10. Tabrizian P, Jibara G, Shrager B, Schwartz ME, Roayaie S. Hepatic resection for primary hepatolithiasis: a single-center Western experience. J Am Coll Surg. 2012 Nov; 215(5):622-6.
      View in: PubMed
    11. Shrager B, Jibara GA, Tabrizian P, Schwartz ME, Labow DM, Hiotis S. Resection of large hepatocellular carcinoma (=10 cm): a unique western perspective. J Surg Oncol. 2013 Feb; 107(2):111-7.
      View in: PubMed
    12. Tabrizian P, Jibara G, Shrager B, Elsabbagh AM, Roayaie S, Schwartz ME. Diaphragmatic hernia after hepatic resection: case series at a single Western institution. J Gastrointest Surg. 2012 Oct; 16(10):1910-4.
      View in: PubMed
    13. Lachenmayer A, Alsinet C, Savic R, Cabellos L, Toffanin S, Hoshida Y, Villanueva A, Minguez B, Newell P, Tsai HW, Barretina J, Thung S, Ward SC, Bruix J, Mazzaferro V, Schwartz M, Friedman SL, Llovet JM. Wnt-pathway activation in two molecular classes of hepatocellular carcinoma and experimental modulation by sorafenib. Clin Cancer Res. 2012 Sep 15; 18(18):4997-5007.
      View in: PubMed
    14. Shrager B, Jibara G, Schwartz M, Roayaie S. Resection of hepatocellular carcinoma without cirrhosis. Ann Surg. 2012 Jun; 255(6):1135-43.
      View in: PubMed
    15. Spaunhurst KM, Hogendorf AM, Smith FJ, Lingala B, Schwartz ME, Cywinska-Bernas A, Zeman KJ, Tang JY. Pachyonychia congenita patients with mutations in KRT6A have more extensive disease compared with patients who have mutations in KRT16. Br J Dermatol. 2012 Apr; 166(4):875-8.
      View in: PubMed
    16. Tabrizian P, Schwartz ME. Surgical management of hepatocellular carcinoma. Mt Sinai J Med. 2012 Mar-Apr; 79(2):223-31.
      View in: PubMed
    17. Zhu H, Qin L, Zhong M, Gordon R, Raoufi M, Hechtman JF, Schwartz M, Roayaie S, Klimstra DS. Carcinoma ex microcystic adenoma of the pancreas: a report of a novel form of malignancy in serous neoplasms. Am J Surg Pathol. 2012 Feb; 36(2):305-10.
      View in: PubMed
    18. Curran T, Tulin-Silver S, Patel K, Ward S, Schneiderman M, Harpaz N, Schwartz M, Itzkowitz S, Warner RR, Kim MK. Prognostic clinicopathologic factors in longitudinally followed patients with metastatic small bowel carcinoid tumors. Pancreas. 2011 Nov; 40(8):1253-7.
      View in: PubMed
    19. Mínguez B, Hoshida Y, Villanueva A, Toffanin S, Cabellos L, Thung S, Mandeli J, Sia D, April C, Fan JB, Lachenmayer A, Savic R, Roayaie S, Mazzaferro V, Bruix J, Schwartz M, Friedman SL, Llovet JM. Gene-expression signature of vascular invasion in hepatocellular carcinoma. J Hepatol. 2011 Dec; 55(6):1325-31.
      View in: PubMed
    20. Villanueva A, Hoshida Y, Battiston C, Tovar V, Sia D, Alsinet C, Cornella H, Liberzon A, Kobayashi M, Kumada H, Thung SN, Bruix J, Newell P, April C, Fan JB, Roayaie S, Mazzaferro V, Schwartz ME, Llovet JM. Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma. Gastroenterology. 2011 May; 140(5):1501-12.e2.
      View in: PubMed
    21. Roayaie S, Bassi D, Tarchi P, Labow D, Schwartz M. Second hepatic resection for recurrent hepatocellular cancer: a Western experience. J Hepatol. 2011 Aug; 55(2):346-50.
      View in: PubMed
    22. Søndenaa K, Gondolesi GE, Roayaie S, Goldman JS, Hausken T, Schwartz ME. Functional abdominal complaints occurred frequently in living liver donors after donation. Scand J Gastroenterol. 2011 May; 46(5):611-5.
      View in: PubMed
    23. Konstadoulakis MM, Roayaie S, Gomatos IP, Labow D, Fiel MI, Miller CM, Schwartz ME. Surgical resection for advanced gallbladder carcinoma. The Mount Sinai experience. Hepatogastroenterology. 2010 Sep-Oct; 57(102-103):1005-12.
      View in: PubMed
    24. Hamilton JP, Chen G, Thomason ME, Schwartz ME, Gotlib IH. Investigating neural primacy in Major Depressive Disorder: multivariate Granger causality analysis of resting-state fMRI time-series data. Mol Psychiatry. 2011 Jul; 16(7):763-72.
      View in: PubMed
    25. Pomfret EA, Washburn K, Wald C, Nalesnik MA, Douglas D, Russo M, Roberts J, Reich DJ, Schwartz ME, Mieles L, Lee FT, Florman S, Yao F, Harper A, Edwards E, Freeman R, Lake J. Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States. Liver Transpl. 2010 Mar; 16(3):262-78.
      View in: PubMed
    26. Sotiropoulos GC, Miyazaki M, Konstadoulakis MM, Paul A, Molmenti EP, Gomatos IP, Radtke A, Baba HA, Beckebaum S, Brokalaki EI, Ohtsuka M, Schwartz ME, Broelsch CE, Sgourakis G. Multicentric evaluation of a clinical and prognostic scoring system predictive of survival after resection of intrahepatic cholangiocarcinomas. Liver Int. 2010 Aug; 30(7):996-1002.
      View in: PubMed
    27. Manizate F, Hiotis SP, Labow D, Roayaie S, Schwartz M. Liver functional reserve estimation: state of the art and relevance for local treatments: the Western perspective. J Hepatobiliary Pancreat Sci. 2010 Jul; 17(4):385-8.
      View in: PubMed
    28. Kao J, Packer S, Vu HL, Schwartz ME, Sung MW, Stock RG, Lo YC, Huang D, Chen SH, Cesaretti JA. Phase 1 study of concurrent sunitinib and image-guided radiotherapy followed by maintenance sunitinib for patients with oligometastases: acute toxicity and preliminary response. Cancer. 2009 Aug 1; 115(15):3571-80.
      View in: PubMed
    29. Roayaie S, Blume IN, Thung SN, Guido M, Fiel MI, Hiotis S, Labow DM, Llovet JM, Schwartz ME. A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma. Gastroenterology. 2009 Sep; 137(3):850-5.
      View in: PubMed
    30. Newell P, Toffanin S, Villanueva A, Chiang DY, Minguez B, Cabellos L, Savic R, Hoshida Y, Lim KH, Melgar-Lesmes P, Yea S, Peix J, Deniz K, Fiel MI, Thung S, Alsinet C, Tovar V, Mazzaferro V, Bruix J, Roayaie S, Schwartz M, Friedman SL, Llovet JM. Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo. J Hepatol. 2009 Oct; 51(4):725-33.
      View in: PubMed
    31. Hong F, Tuyama A, Lee TF, Loke J, Agarwal R, Cheng X, Garg A, Fiel MI, Schwartz M, Walewski J, Branch A, Schecter AD, Bansal MB. Hepatic stellate cells express functional CXCR4: role in stromal cell-derived factor-1alpha-mediated stellate cell activation. Hepatology. 2009 Jun; 49(6):2055-67.
      View in: PubMed
    32. Ozao-Choy J, Ma G, Kao J, Wang GX, Meseck M, Sung M, Schwartz M, Divino CM, Pan PY, Chen SH. The novel role of tyrosine kinase inhibitor in the reversal of immune suppression and modulation of tumor microenvironment for immune-based cancer therapies. Cancer Res. 2009 Mar 15; 69(6):2514-22.
      View in: PubMed
    33. Sarpel U, Hefti MM, Wisnievsky JP, Roayaie S, Schwartz ME, Labow DM. Outcome for patients treated with laparoscopic versus open resection of hepatocellular carcinoma: case-matched analysis. Ann Surg Oncol. 2009 Jun; 16(6):1572-7.
      View in: PubMed
    34. Mazzaferro V, Llovet JM, Miceli R, Bhoori S, Schiavo M, Mariani L, Camerini T, Roayaie S, Schwartz ME, Grazi GL, Adam R, Neuhaus P, Salizzoni M, Bruix J, Forner A, De Carlis L, Cillo U, Burroughs AK, Troisi R, Rossi M, Gerunda GE, Lerut J, Belghiti J, Boin I, Gugenheim J, Rochling F, Van Hoek B, Majno P. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol. 2009 Jan; 10(1):35-43.
      View in: PubMed
    35. Sarpel U, Bonavia AS, Grucela A, Roayaie S, Schwartz ME, Labow DM. Does anatomic versus nonanatomic resection affect recurrence and survival in patients undergoing surgery for colorectal liver metastasis? Ann Surg Oncol. 2009 Feb; 16(2):379-84.
      View in: PubMed
    36. Babyatsky M, Lin J, Yio X, Chen A, Zhang JY, Zheng Y, Twyman C, Bao X, Schwartz M, Thung S, Lawrence Werther J, Itzkowitz S. Trefoil factor-3 expression in human colon cancer liver metastasis. Clin Exp Metastasis. 2009; 26(2):143-51.
      View in: PubMed
    37. Sterling RK, Jeffers L, Gordon F, Venook AP, Reddy KR, Satomura S, Kanke F, Schwartz ME, Sherman M. Utility of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxy prothrombin, alone or in combination, as biomarkers for hepatocellular carcinoma. Clin Gastroenterol Hepatol. 2009 Jan; 7(1):104-13.
      View in: PubMed
    38. Villanueva A, Chiang DY, Newell P, Peix J, Thung S, Alsinet C, Tovar V, Roayaie S, Minguez B, Sole M, Battiston C, Van Laarhoven S, Fiel MI, Di Feo A, Hoshida Y, Yea S, Toffanin S, Ramos A, Martignetti JA, Mazzaferro V, Bruix J, Waxman S, Schwartz M, Meyerson M, Friedman SL, Llovet JM. Pivotal role of mTOR signaling in hepatocellular carcinoma. Gastroenterology. 2008 Dec; 135(6):1972-83, 1983.e1-11.
      View in: PubMed
    39. Schwartz M, Weintraub J. Combined transarterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma. Nat Clin Pract Oncol. 2008 Nov; 5(11):630-1.
      View in: PubMed
    40. Roayaie S, Schwartz ME. Expansion of criteria for transplanting patients with hepatocellular carcinoma. Liver Transpl. 2008 Aug; 14(8):1071-2.
      View in: PubMed
    41. Schwartz ME, Roayaie S, Konstadoulakis MM, Gomatos IP, Miller CM. The Mount Sinai experience with orthotopic liver transplantation for benign tumors: brief report and literature review: case reports. Transplant Proc. 2008 Jun; 40(5):1759-62.
      View in: PubMed
    42. Killackey MT, Gondolesi GE, Liu LU, Paramesh AS, Thung SN, Suriawinata A, Nguyen E, Roayaie S, Schwartz ME, Emre S, Schiano TD. Effect of ischemia-reperfusion on the incidence of acute cellular rejection and timing of histologic hepatitis C virus recurrence after liver transplantation. Transplant Proc. 2008 Jun; 40(5):1504-10.
      View in: PubMed
    43. Schwartz M, Dvorchik I, Roayaie S, Fiel MI, Finkelstein S, Marsh JW, Martignetti JA, Llovet JM. Liver transplantation for hepatocellular carcinoma: extension of indications based on molecular markers. J Hepatol. 2008 Oct; 49(4):581-8.
      View in: PubMed
    44. Konstadoulakis MM, Roayaie S, Gomatos IP, Labow D, Fiel MI, Miller CM, Schwartz ME. Aggressive surgical resection for hilar cholangiocarcinoma: is it justified? Audit of a single center's experience. Am J Surg. 2008 Aug; 196(2):160-9.
      View in: PubMed
    45. Scordi-Bello IA, Snyder A, Schwartz M, Fallon JT. Intravascular epithelioid hemangioendothelioma of the inferior vena cava: case report of an unusual and unpredictable vascular tumor. Cardiovasc Pathol. 2009 Jul-Aug; 18(4):243-6.
      View in: PubMed
    46. Mazzaferro V, Chun YS, Poon RT, Schwartz ME, Yao FY, Marsh JW, Bhoori S, Lee SG. Liver transplantation for hepatocellular carcinoma. Ann Surg Oncol. 2008 Apr; 15(4):1001-7.
      View in: PubMed
    47. Konstadoulakis MM, Roayaie S, Gomatos IP, Labow D, Fiel MI, Miller CM, Schwartz ME. Fifteen-year, single-center experience with the surgical management of intrahepatic cholangiocarcinoma: operative results and long-term outcome. Surgery. 2008 Mar; 143(3):366-74.
      View in: PubMed
    48. Schwartz ME, D'Amico F, Vitale A, Emre S, Cillo U. Liver transplantation for hepatocellular carcinoma: Are the Milan criteria still valid? Eur J Surg Oncol. 2008 Mar; 34(3):256-62.
      View in: PubMed
    49. Sarpel U, Schwartz M. Liver transplantation for hepatocellular carcinoma. Hepatol Res. 2007 Sep; 37 Suppl 2:S264-6.
      View in: PubMed
    50. Sterling RK, Jeffers L, Gordon F, Sherman M, Venook AP, Reddy KR, Satomura S, Schwartz ME. Clinical utility of AFP-L3% measurement in North American patients with HCV-related cirrhosis. Am J Gastroenterol. 2007 Oct; 102(10):2196-205.
      View in: PubMed
    51. Schwartz M, Roayaie S, Konstadoulakis M. Strategies for the management of hepatocellular carcinoma. Nat Clin Pract Oncol. 2007 Jul; 4(7):424-32.
      View in: PubMed
    52. Schwartz M, Roayaie S, Uva P. Treatment of HCC in patients awaiting liver transplantation. Am J Transplant. 2007 Aug; 7(8):1875-81.
      View in: PubMed
    53. Silverberg D, Wellner R, Arora S, Newell P, Ozao J, Sarpel U, Torrina P, Wolfeld M, Divino C, Schwartz M, Silver L, Marin M. Establishing an international training program for surgical residents. J Surg Educ. 2007 May-Jun; 64(3):143-9.
      View in: PubMed
    54. Wurmbach E, Chen YB, Khitrov G, Zhang W, Roayaie S, Schwartz M, Fiel I, Thung S, Mazzaferro V, Bruix J, Bottinger E, Friedman S, Waxman S, Llovet JM. Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma. Hepatology. 2007 Apr; 45(4):938-47.
      View in: PubMed
    55. Sarpel U, Roayaie S, Schwartz ME, Labow DM. The role of fibrin sealants in hepatic surgery. Surg Technol Int. 2007; 16:31-6.
      View in: PubMed
    56. Kremer-Tal S, Narla G, Chen Y, Hod E, DiFeo A, Yea S, Lee JS, Schwartz M, Thung SN, Fiel IM, Banck M, Zimran E, Thorgeirsson SS, Mazzaferro V, Bruix J, Martignetti JA, Llovet JM, Friedman SL. Downregulation of KLF6 is an early event in hepatocarcinogenesis, and stimulates proliferation while reducing differentiation. J Hepatol. 2007 Apr; 46(4):645-54.
      View in: PubMed
    57. Schwartz M. Liver transplantation: the preferred treatment for early hepatocellular carcinoma in the setting of cirrhosis? Ann Surg Oncol. 2007 Feb; 14(2):548-52.
      View in: PubMed
    58. Llovet JM, Chen Y, Wurmbach E, Roayaie S, Fiel MI, Schwartz M, Thung SN, Khitrov G, Zhang W, Villanueva A, Battiston C, Mazzaferro V, Bruix J, Waxman S, Friedman SL. A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis. Gastroenterology. 2006 Dec; 131(6):1758-67.
      View in: PubMed
    59. Croitoru AG, Hytiroglou P, Schwartz ME, Saxena R. Liver transplantation for liver rupture due to light chain deposition disease: a case report. Semin Liver Dis. 2006 Aug; 26(3):298-303.
      View in: PubMed
    60. Llovet JM, Schwartz M, Fuster J, Bruix J. Expanded criteria for hepatocellular carcinoma through down-staging prior to liver transplantation: not yet there. Semin Liver Dis. 2006 Aug; 26(3):248-53.
      View in: PubMed
    61. Schiano TD, Gutierrez JA, Walewski JL, Fiel MI, Cheng B, Bodenheimer H, Thung SN, Chung RT, Schwartz ME, Bodian C, Branch AD. Accelerated hepatitis C virus kinetics but similar survival rates in recipients of liver grafts from living versus deceased donors. Hepatology. 2005 Dec; 42(6):1420-8.
      View in: PubMed
    62. Carmiel-Haggai M, Fiel MI, Gaddipati HC, Abittan C, Hossain S, Roayaie S, Schwartz ME, Gondolesi G, Emre S, Schiano TD. Recurrent hepatitis C after retransplantation: factors affecting graft and patient outcome. Liver Transpl. 2005 Dec; 11(12):1567-73.
      View in: PubMed
    63. Liu LU, Bodian CA, Gondolesi GE, Schwartz ME, Emre S, Roayaie S, Schiano TD. Marked Differences in acute cellular rejection rates between living-donor and deceased-donor liver transplant recipients. Transplantation. 2005 Oct 27; 80(8):1072-80.
      View in: PubMed
    64. Schwartz JD, Sung M, Schwartz M, Lehrer D, Mandeli J, Liebes L, Goldenberg A, Volm M. Thalidomide in advanced hepatocellular carcinoma with optional low-dose interferon-alpha2a upon progression. Oncologist. 2005 Oct; 10(9):718-27.
      View in: PubMed
    65. Schwartz M, Roayaie S, Llovet J. How should patients with hepatocellular carcinoma recurrence after liver transplantation be treated? J Hepatol. 2005 Oct; 43(4):584-9.
      View in: PubMed
    66. Marsh JW, Finkelstein SD, Schwartz ME, Fiel MI, Dvorchik I. Advancing the diagnosis and treatment of hepatocellular carcinoma. Liver Transpl. 2005 Apr; 11(4):469-72.
      View in: PubMed
    67. Llovet JM, Schwartz M, Mazzaferro V. Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis. 2005; 25(2):181-200.
      View in: PubMed
    68. Kremer-Tal S, Reeves HL, Narla G, Thung SN, Schwartz M, Difeo A, Katz A, Bruix J, Bioulac-Sage P, Martignetti JA, Friedman SL. Frequent inactivation of the tumor suppressor Kruppel-like factor 6 (KLF6) in hepatocellular carcinoma. Hepatology. 2004 Nov; 40(5):1047-52.
      View in: PubMed
    69. Schwartz M. Liver transplantation for hepatocellular carcinoma. Gastroenterology. 2004 Nov; 127(5 Suppl 1):S268-76.
      View in: PubMed
    70. Schwartz M, Madariaga J, Hirose R, Shaver TR, Sher L, Chari R, Colonna JO, Heaton N, Mirza D, Adams R, Rees M, Lloyd D. Comparison of a new fibrin sealant with standard topical hemostatic agents. Arch Surg. 2004 Nov; 139(11):1148-54.
      View in: PubMed
    71. Silverberg D, Paramesh AS, Roayaie S, Schwartz ME. Giant hemangioma of the adrenal. Isr Med Assoc J. 2004 Nov; 6(11):705-6.
      View in: PubMed
    72. Gondolesi GE, Varotti G, Florman SS, Muñoz L, Fishbein TM, Emre SH, Schwartz ME, Miller C. Biliary complications in 96 consecutive right lobe living donor transplant recipients. Transplantation. 2004 Jun 27; 77(12):1842-8.
      View in: PubMed
    73. Bu-Ghanim M, Suriawinata A, Killackey M, Schwartz ME, Jaffe D, Fiel MI. Invasive colloid carcinoma arising from intraductal papillary neoplasm in a 50-year-old woman with primary sclerosing cholangitis. Semin Liver Dis. 2004 May; 24(2):209-13.
      View in: PubMed
    74. Roayaie S, Schwartz JD, Sung MW, Emre SH, Miller CM, Gondolesi GE, Krieger NR, Schwartz ME. Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis. Liver Transpl. 2004 Apr; 10(4):534-40.
      View in: PubMed
    75. Varotti G, Gondolesi GE, Goldman J, Wayne M, Florman SS, Schwartz ME, Miller CM, Sukru E. Anatomic variations in right liver living donors. J Am Coll Surg. 2004 Apr; 198(4):577-82.
      View in: PubMed
    76. Florman S, Schiano T, Kim L, Maman D, Levay A, Gondolesi G, Fishbein T, Emre S, Schwartz M, Miller C, Sheiner P. The incidence and significance of late acute cellular rejection (>1000 days) after liver transplantation. Clin Transplant. 2004 Apr; 18(2):152-5.
      View in: PubMed
    77. Florman S, Toure B, Kim L, Gondolesi G, Roayaie S, Krieger N, Fishbein T, Emre S, Miller C, Schwartz M. Liver transplantation for neuroendocrine tumors. J Gastrointest Surg. 2004 Feb; 8(2):208-12.
      View in: PubMed
    78. Schwartz M. Liver transplantation in patients with hepatocellular carcinoma. Liver Transpl. 2004 Feb; 10(2 Suppl 1):S81-5.
      View in: PubMed
    79. Gondolesi GE, Roayaie S, Muñoz L, Kim-Schluger L, Schiano T, Fishbein TM, Emre S, Miller CM, Schwartz ME. Adult living donor liver transplantation for patients with hepatocellular carcinoma: extending UNOS priority criteria. Ann Surg. 2004 Feb; 239(2):142-9.
      View in: PubMed
    80. Paramesh AS, Roayaie S, Doan Y, Schwartz ME, Emre S, Fishbein T, Florman S, Gondolesi GE, Krieger N, Ames S, Bromberg JS, Akalin E. Post-liver transplant acute renal failure: factors predicting development of end-stage renal disease. Clin Transplant. 2004 Feb; 18(1):94-9.
      View in: PubMed
    81. Roayaie S, Schiano TD, Thung SN, Emre SH, Fishbein TM, Miller CM, Schwartz ME. Results of retransplantation for recurrent hepatitis C. Hepatology. 2003 Dec; 38(6):1428-36.
      View in: PubMed
    82. Varotti G, Gondolesi GE, Roayaie S, Suriawinata A, Soltys K, Fishbein TM, Schwartz ME, Miller C. Combined adult-to-adult living donor right lobe liver transplantation and pancreatoduodenectomy for distal bile duct adenocarcinoma in a patient with primary sclerosing cholangitis. J Am Coll Surg. 2003 Nov; 197(5):765-9.
      View in: PubMed
    83. Yoshizumi T, Gondolesi GE, Bodian CA, Jeon H, Schwartz ME, Fishbein TM, Miller CM, Emre S. A simple new formula to assess liver weight. Transplant Proc. 2003 Jun; 35(4):1415-20.
      View in: PubMed
    84. Goldman J, Florman S, Varotti G, Gondolesi GE, Gerning A, Fishbein T, Kim L, Schwartz ME. Noninvasive preoperative evaluation of biliary anatomy in right-lobe living donors with mangafodipir trisodium-enhanced MR cholangiography. Transplant Proc. 2003 Jun; 35(4):1421-2.
      View in: PubMed
    85. Schwartz M. Candidate selection criteria for living donor liver transplantation. Mt Sinai J Med. 2003 May; 70(3):171-3.
      View in: PubMed
    86. Schwartz JD, Schwartz M, Mandeli J, Sung M. Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials. Lancet Oncol. 2002 Oct; 3(10):593-603.
      View in: PubMed
    87. Liu LU, Schiano TD, Min AD, Kim-Schluger L, Schwartz ME, Emre S, Fishbein TM, Bodenheimer HC, Miller CM. Syngeneic living-donor liver transplantation without the use of immunosuppression. Gastroenterology. 2002 Oct; 123(4):1341-5.
      View in: PubMed
    88. Gondolesi GE, Florman S, Matsumoto C, Huang R, Fishbein TM, Sheiner PA, Schwartz ME, Emre S, Thung S, Shapiro R, Miller CM. Venous hemodynamics in living donor right lobe liver transplantation. Liver Transpl. 2002 Sep; 8(9):809-13.
      View in: PubMed
    89. Kurian MS, Gagner M, Murakami Y, Andrei V, Jossart G, Schwartz M. Hand-assisted laparoscopic donor hepatectomy for living related transplantation in the porcine model. Surg Laparosc Endosc Percutan Tech. 2002 Aug; 12(4):232-7.
      View in: PubMed
    90. Fishbein TM, Schiano T, LeLeiko N, Facciuto M, Ben-Haim M, Emre S, Sheiner PA, Schwartz ME, Miller CM. An integrated approach to intestinal failure: results of a new program with total parenteral nutrition, bowel rehabilitation, and transplantation. J Gastrointest Surg. 2002 Jul-Aug; 6(4):554-62.
      View in: PubMed
    91. Kim-Schluger L, Florman SS, Schiano T, O'Rourke M, Gagliardi R, Drooker M, Emre S, Fishbein TM, Sheiner PA, Schwartz ME, Miller CM. Quality of life after lobectomy for adult liver transplantation. Transplantation. 2002 May 27; 73(10):1593-7.
      View in: PubMed
    92. Roayaie S, Frischer JS, Emre SH, Fishbein TM, Sheiner PA, Sung M, Miller CM, Schwartz ME. Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters. Ann Surg. 2002 Apr; 235(4):533-9.
      View in: PubMed
    93. Gondolesi G, Muñoz L, Matsumoto C, Fishbein T, Sheiner P, Emre S, Miller C, Schwartz ME. Hepatocellular carcinoma: a prime indication for living donor liver transplantation. J Gastrointest Surg. 2002 Jan-Feb; 6(1):102-7.
      View in: PubMed
    94. Muñoz L, Roayaie S, Maman D, Fishbein T, Sheiner P, Emre S, Miller C, Schwartz ME. Hilar cholangiocarcinoma involving the portal vein bifurcation: long-term results after resection. J Hepatobiliary Pancreat Surg. 2002; 9(2):237-41.
      View in: PubMed
    95. Gondolesi GE, Matsumoto C, Wayne M, Schwartz ME. Post-traumatic pseudoaneurysm of the common hepatic artery with duodenal fistula. HPB (Oxford). 2002; 4(4):183-6.
      View in: PubMed
    96. Ben-Haim M, Emre S, Fishbein TM, Sheiner PA, Bodian CA, Kim-Schluger L, Schwartz ME, Miller CM. Critical graft size in adult-to-adult living donor liver transplantation: impact of the recipient's disease. Liver Transpl. 2001 Nov; 7(11):948-53.
      View in: PubMed
    97. Emre S, Atillasoy EO, Ozdemir S, Schilsky M, Rathna Varma CV, Thung SN, Sternlieb I, Guy SR, Sheiner PA, Schwartz ME, Miller CM. Orthotopic liver transplantation for Wilson's disease: a single-center experience. Transplantation. 2001 Oct 15; 72(7):1232-6.
      View in: PubMed
    98. Miller CM, Gondolesi GE, Florman S, Matsumoto C, Muñoz L, Yoshizumi T, Artis T, Fishbein TM, Sheiner PA, Kim-Schluger L, Schiano T, Shneider BL, Emre S, Schwartz ME. One hundred nine living donor liver transplants in adults and children: a single-center experience. Ann Surg. 2001 Sep; 234(3):301-11; discussion 311-2.
      View in: PubMed
    99. Sung MW, Yeh HC, Thung SN, Schwartz ME, Mandeli JP, Chen SH, Woo SL. Intratumoral adenovirus-mediated suicide gene transfer for hepatic metastases from colorectal adenocarcinoma: results of a phase I clinical trial. Mol Ther. 2001 Sep; 4(3):182-91.
      View in: PubMed
    100. Shapiro RS, Fishbein T, Schwartz M, Miller CM. Use of intraoperative Doppler ultrasound to diagnose hepatic venous obstruction in a right lobe living donor liver transplant. Liver Transpl. 2001 Jun; 7(6):547-50.
      View in: PubMed
    101. Emre S, Gondolesi G, Polat K, Ben-Haim M, Artis T, Fishbein TM, Sheiner PA, Kim-Schluger L, Schwartz ME, Miller CM. Use of daclizumab as initial immunosuppression in liver transplant recipients with impaired renal function. Liver Transpl. 2001 Mar; 7(3):220-5.
      View in: PubMed
    102. Zier K, Maddux JM, Johnson K, Sung M, Mandeli J, Eisenbach L, Schwartz M. Surrogate markers of antitumor responses: in vitro activation of T cells by autologous tumor peptides. Clin Cancer Res. 2001 Mar; 7(3 Suppl):818s-821s.
      View in: PubMed
    103. Sheiner PA, Florman SS, Emre S, Fishbein T, Schwartz ME, Miller CM, Boros P. Recurrence of hepatitis C after liver transplantation is associated with increased systemic IL-10 levels. Mediators Inflamm. 2001 Feb; 10(1):37-41.
      View in: PubMed
    104. Emre S, Soejima Y, Altaca G, Facciuto M, Fishbein TM, Sheiner PA, Schwartz ME, Miller CM. Safety and risk of using pediatric donor livers in adult liver transplantation. Liver Transpl. 2001 Jan; 7(1):41-7.
      View in: PubMed
    105. Roayaie S, Haim MB, Emre S, Fishbein TM, Sheiner PA, Miller CM, Schwartz ME. Comparison of surgical outcomes for hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: a western experience. Ann Surg Oncol. 2000 Dec; 7(10):764-70.
      View in: PubMed
    106. Batheja N, Suriawinata A, Saxena R, Ionescu G, Schwartz M, Thung SN. Expression of p53 and PCNA in cholangiocarcinoma and primary sclerosing cholangitis. Mod Pathol. 2000 Dec; 13(12):1265-8.
      View in: PubMed
    107. Reich DJ, Fiel I, Guarrera JV, Emre S, Guy SR, Schwartz ME, Miller CM, Sheiner PA. Liver transplantation for autoimmune hepatitis. Hepatology. 2000 Oct; 32(4 Pt 1):693-700.
      View in: PubMed
    108. Fishbein T, Facciuto M, Harpaz N, Leytin A, Emre S, Sheiner P, Schwartz M, Miller C. A simple blood flush technique and mannitol promote hemodynamic stability and avoid reperfusion injury in isolated intestinal transplantation. Transplant Proc. 2000 Sep; 32(6):1313-4.
      View in: PubMed
    109. Fishbein T, Schiano T, Jaffe D, Kim-Schluger L, Facciuto M, Emre S, Sheiner P, Schwartz M, O'Rourke M, Miller C. Isolated intestinal transplantation in adults with nonreconstructible GI tracts. Transplant Proc. 2000 Sep; 32(6):1231-2.
      View in: PubMed
    110. Zier K, Johnson K, Maddux JM, Sung M, Mandeli J, Eisenbach L, Schwartz M. IFNgamma secretion following stimulation with total tumor peptides from autologous human tumors. J Immunol Methods. 2000 Jul 31; 241(1-2):61-8.
      View in: PubMed
    111. Gambarin-Gelwan M, Wolf DC, Shapiro R, Schwartz ME, Min AD. Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in cirrhotic patients undergoing liver transplantation. Am J Gastroenterol. 2000 Jun; 95(6):1535-8.
      View in: PubMed
    112. Sheiner PA, Magliocca JF, Bodian CA, Kim-Schluger L, Altaca G, Guarrera JV, Emre S, Fishbein TM, Guy SR, Schwartz ME, Miller CM. Long-term medical complications in patients surviving > or = 5 years after liver transplant. Transplantation. 2000 Mar 15; 69(5):781-9.
      View in: PubMed
    113. Facciuto M, Heidt D, Guarrera J, Bodian CA, Miller CM, Emre S, Guy SR, Fishbein TM, Schwartz ME, Sheiner PA. Retransplantation for late liver graft failure: predictors of mortality. Liver Transpl. 2000 Mar; 6(2):174-9.
      View in: PubMed
    114. Schiano TD, Bodian C, Schwartz ME, Glajchen N, Min AD. Accuracy and significance of computed tomographic scan assessment of hepatic volume in patients undergoing liver transplantation. Transplantation. 2000 Feb 27; 69(4):545-50.
      View in: PubMed
    115. Emre S, Kitibayashi K, Schwartz ME, Ahn J, Birnbaum A, Thung SN, Miller CM. Liver transplantation in a patient with acute liver failure due to sickle cell intrahepatic cholestasis. Transplantation. 2000 Feb 27; 69(4):675-6.
      View in: PubMed
    116. Bronster DJ, Emre S, Boccagni P, Sheiner PA, Schwartz ME, Miller CM. Central nervous system complications in liver transplant recipients--incidence, timing, and long-term follow-up. Clin Transplant. 2000 Feb; 14(1):1-7.
      View in: PubMed
    117. Roayaie S, Sheiner PA, Emre S, Guy S, Schwartz ME, Boros P, Miller CM. Cytokine profiles in early rejection following OKT3 treatment in liver transplant patients. Mediators Inflamm. 2000; 9(3-4):141-6.
      View in: PubMed
    118. Suriawinata A, Ivanov K, Ben Haim M, Schwartz ME. A 67-year-old man with hepatitis C virus infection and a liver tumor. Semin Liver Dis. 2000; 20(2):227-31.
      View in: PubMed
    119. Granot E, Tarcsafalvi A, Emre S, Sheiner P, Guy S, Schwartz ME, Boros P, Miller CM. Th1/Th2 cytokines and ICAM-1 levels post-liver transplant do not predict early rejection. Mediators Inflamm. 2000; 9(1):35-8.
      View in: PubMed
    120. Emre S, Genyk Y, Schluger LK, Fishbein TM, Guy SR, Sheiner PA, Schwartz ME, Miller CM. Treatment of tacrolimus-related adverse effects by conversion to cyclosporine in liver transplant recipients. Transpl Int. 2000; 13(1):73-8.
      View in: PubMed
    121. Kim-Schluger L, Florman SS, Gondolesi G, Emre S, Sheiner PA, Fishbein TM, Schwartz ME, Miller CM. Liver transplantation at Mount Sinai. Clin Transpl. 2000; 247-53.
      View in: PubMed
    122. Ben-Haim M, Roayaie S, Ye MQ, Thung SN, Emre S, Fishbein TA, Sheiner PM, Miller CM, Schwartz ME. Hepatic epithelioid hemangioendothelioma: resection or transplantation, which and when? Liver Transpl Surg. 1999 Nov; 5(6):526-31.
      View in: PubMed
    123. Emre S, Sebastian A, Chodoff L, Boccagni P, Meyers B, Sheiner PA, Mor E, Guy SR, Atillasoy E, Schwartz ME, Miller CM. Selective decontamination of the digestive tract helps prevent bacterial infections in the early postoperative period after liver transplant. Mt Sinai J Med. 1999 Oct-Nov; 66(5-6):310-3.
      View in: PubMed
    124. Emre S, Schwartz ME, Shneider B, Hojsak J, Kim-Schluger L, Fishbein TM, Guy SR, Sheiner PA, LeLeiko NS, Birnbaum A, Suchy FJ, Miller CM. Living related liver transplantation for acute liver failure in children. Liver Transpl Surg. 1999 May; 5(3):161-5.
      View in: PubMed
    125. Norton KI, Glass RB, Kogan D, Emre S, Schwartz M, Shneider BL. MR cholangiography in children and young adults with biliary disease. AJR Am J Roentgenol. 1999 May; 172(5):1239-44.
      View in: PubMed
    126. Fishbein TM, Emre S, Guy SR, Sheiner PA, Kim LH, Schwartz ME, Miller CM. Safe transplantation of blood type A2 livers to blood type O recipients. Transplantation. 1999 Apr 15; 67(7):1071-3.
      View in: PubMed
    127. Basile J, Busuttil A, Sheiner PA, Emre S, Guy S, Schwartz ME, Boros P, Miller CM. Correlation between von Willebrand factor levels and early graft function in clinical liver transplantation. Clin Transplant. 1999 Feb; 13(1 Pt 1):25-31.
      View in: PubMed
    128. Guy SR, Magliocca JF, Fruchtman S, McDonough P, Emre S, Kim-Schluger L, Sheiner PA, Fishbein TM, Schwartz ME, Miller CM. Transmission of factor VII deficiency through liver transplantation. Transpl Int. 1999; 12(4):278-80.
      View in: PubMed
    129. Ye MQ, Suriawinata A, Ben Haim M, Parsons R, Schwartz ME. A 42-year-old woman with liver masses and long-term use of oral contraceptives. Semin Liver Dis. 1999; 19(3):339-44.
      View in: PubMed
    130. Min AD, Saxena R, Thung SN, Atillasoy EO, Wolf DC, Sauter B, Schwartz ME, Bodenheimer HC. Outcome of hepatitis C patients with and without hepatocellular carcinoma undergoing liver transplant. Am J Gastroenterol. 1998 Nov; 93(11):2148-53.
      View in: PubMed
    131. Roayaie S, Guarrera JV, Ye MQ, Thung SN, Emre S, Fishbein TM, Guy SR, Sheiner PA, Miller CM, Schwartz ME. Aggressive surgical treatment of intrahepatic cholangiocarcinoma: predictors of outcomes. J Am Coll Surg. 1998 Oct; 187(4):365-72.
      View in: PubMed
    132. Kelly DM, Emre S, Guy SR, Miller CM, Schwartz ME, Sheiner PA. Liver transplant recipients are not at increased risk for nonlymphoid solid organ tumors. Cancer. 1998 Sep 15; 83(6):1237-43.
      View in: PubMed
    133. Sheiner PA, Boros P, Klion FM, Thung SN, Schluger LK, Lau JY, Mor E, Bodian C, Guy SR, Schwartz ME, Emre S, Bodenheimer HC, Miller CM. The efficacy of prophylactic interferon alfa-2b in preventing recurrent hepatitis C after liver transplantation. Hepatology. 1998 Sep; 28(3):831-8.
      View in: PubMed
    134. Suehiro T, Boros P, Emre S, Sheiner PA, Guy S, Schwartz ME, Miller CM. Donor des-gamma-carboxy prothrombin positivity is a risk factor for poor early graft function in liver transplantation. Transpl Int. 1998; 11(2):143-6.
      View in: PubMed
    135. Boros P, Suehiro T, Curtiss S, Sheiner P, Emre S, Guy S, Schwartz ME, Miller CM. Differential contribution of graft and recipient to perioperative TNF-alpha, IL-1 beta, IL-6 and IL-8 levels and correlation with early graft function in clinical liver transplantation. Clin Transplant. 1997 Dec; 11(6):588-92.
      View in: PubMed
    136. Suehiro T, Boros P, Emre S, Sheiner P, Guy S, Schwartz ME, Miller CM. Assessment of liver allograft function by hyaluronic acid and endothelin levels. J Surg Res. 1997 Dec; 73(2):123-8.
      View in: PubMed
    137. Mor E, Yussim A, Chodoff L, Schwartz ME. New immunosuppressive agents for maintenance therapy in organ transplantation. BioDrugs. 1997 Dec; 8(6):469-88.
      View in: PubMed
    138. Altaca G, Scigliano E, Guy SR, Sheiner PA, Reich DJ, Schwartz ME, Miller CM, Emre S. Persistent hypersplenism early after liver transplant: the role of splenectomy. Transplantation. 1997 Nov 27; 64(10):1481-3.
      View in: PubMed
    139. Sheiner PA, Varma CV, Guarrera JV, Cooper J, Garatti M, Emre S, Guy SR, Schwartz ME, Miller CM. Selective revascularization of hepatic artery thromboses after liver transplantation improves patient and graft survival. Transplantation. 1997 Nov 15; 64(9):1295-9.
      View in: PubMed
    140. Katz E, Miller CM, Nour B, Schwartz ME, Sebastian A, Emre S. The first in situ split of a liver in the USA performed by two geographically distant transplant centers--enhancing, sharing, and expanding the cadaveric liver organ pool. J Okla State Med Assoc. 1997 Nov-Dec; 90(8):442-3.
      View in: PubMed
    141. Wolf DC, Freni MA, Boccagni P, Mor E, Chodoff L, Birnbaum A, Miller CM, Schwartz ME, Bodenheimer HC. Low-dose aspirin therapy is associated with few side effects but does not prevent hepatic artery thrombosis in liver transplant recipients. Liver Transpl Surg. 1997 Nov; 3(6):598-603.
      View in: PubMed
    142. Shapiro RS, Varma CV, Schwartz ME, Miller CM. Splenorenal shunt closure after liver transplantation: intraoperative Doppler assessment of portal hemodynamics. Liver Transpl Surg. 1997 Nov; 3(6):641-2.
      View in: PubMed
    143. Sheiner PA, Guarrera JV, Grunstein E, Emre S, Guy SR, Schwartz ME, Miller CM, Boros P. Increased risk of early rejection correlates with recovery of CD3 cell count after liver transplant in patients receiving OKT3 induction. Transplantation. 1997 Oct 27; 64(8):1214-6.
      View in: PubMed
    144. Suehiro T, Boros P, Sheiner P, Emre S, Guy S, Schwartz ME, Miller CM. Effluent levels of thrombomodulin predict early graft function in clinical liver transplantation. Liver. 1997 Oct; 17(5):224-9.
      View in: PubMed
    145. Fishbein TM, Fiel MI, Emre S, Cubukcu O, Guy SR, Schwartz ME, Miller CM, Sheiner PA. Use of livers with microvesicular fat safely expands the donor pool. Transplantation. 1997 Jul 27; 64(2):248-51.
      View in: PubMed
    146. Sher LS, Cosenza CA, Michel J, Makowka L, Miller CM, Schwartz ME, Busuttil R, McDiarmid S, Burdick JF, Klein AS, Esquivel C, Klintmalm G, Levy M, Roberts JP, Lake JR, Kalayoglu M, D'Alessandro AM, Gordon RD, Stieber AC, Shaw BW, Thistlethwaite JR, Whittington P, Wiesner RH, Porayko M, Cosimi AB, et al. Efficacy of tacrolimus as rescue therapy for chronic rejection in orthotopic liver transplantation: a report of the U.S. Multicenter Liver Study Group. Transplantation. 1997 Jul 27; 64(2):258-63.
      View in: PubMed
    147. Min AD, Atillasoy EO, Schwartz ME, Thiim M, Miller CM, Bodenheimer HC. Reassessing the role of medical therapy in the management of hepatic vein thrombosis. Liver Transpl Surg. 1997 Jul; 3(4):423-9.
      View in: PubMed
    148. Sheiner PA, Schluger LK, Emre S, Thung SN, Lau JY, Guy SR, Schwartz ME, Miller CM. Retransplantation for recurrent hepatitis C. Liver Transpl Surg. 1997 Mar; 3(2):130-6.
      View in: PubMed
    149. Suehiro T, Boros P, Emre S, Sheiner P, Guy S, Schwartz M, Miller CM. Value of caval effluent in predicting early graft function after orthotopic liver transplantation. Transplant Proc. 1997 Feb-Mar; 29(1-2):469-70.
      View in: PubMed
    150. Suehiro T, Boros P, Sheiner P, Tarcsafalvi A, Varma S, Emre S, Guy S, Schwartz M, Miller CM. Perioperative hepatocyte growth factor levels and early graft function in clinical liver transplantation. Transplant Proc. 1997 Feb-Mar; 29(1-2):382-3.
      View in: PubMed
    151. Hoffman AL, Emre S, Verham RP, Petrovic LM, Eguchi S, Silverman JL, Geller SA, Schwartz ME, Miller CM, Makowka L. Hepatic angiomyolipoma: two case reports of caudate-based lesions and review of the literature. Liver Transpl Surg. 1997 Jan; 3(1):46-53.
      View in: PubMed
    152. Schwartz ME. Liver transplantation for hepatocellular carcinoma: the best treatment, but for which patient? Hepatology. 1996 Dec; 24(6):1539-41.
      View in: PubMed
    153. Scheiner P, Emre S, Guy SR, Min A, Schwartz ME, Miller CM. The older liver transplant candidate: what are the limits? Liver Transpl Surg. 1996 Sep; 2(5 Suppl 1):9-11.
      View in: PubMed
    154. Kelly D, Emre S, Guy SR, Sheiner PA, Miller CM, Schwartz ME. Resection of benign hepatic lesions with selective use of total vascular isolation. J Am Coll Surg. 1996 Aug; 183(2):113-6.
      View in: PubMed
    155. Emre S, Schwartz ME, Altaca G, Sethi P, Fiel MI, Guy SR, Kelly DM, Sebastian A, Fisher A, Eickmeyer D, Sheiner PA, Miller CM. Safe use of hepatic allografts from donors older than 70 years. Transplantation. 1996 Jul 15; 62(1):62-5.
      View in: PubMed
    156. Shapiro RS, Katz R, Mendelson DS, Halton KP, Schwartz ME, Miller CM. Detection of hepatocellular carcinoma in cirrhotic patients: sensitivity of CT and ultrasonography. J Ultrasound Med. 1996 Jul; 15(7):497-502; quiz 503-4.
      View in: PubMed
    157. Bronster DJ, Lidov MW, Wolfe D, Schwartz ME, Miller CM. Progressive multifocal leukoencephalopathy after orthotopic liver transplantation. Liver Transpl Surg. 1995 Nov; 1(6):371-2.
      View in: PubMed
    158. Emre S, Skerrett D, Kelly D, Sethi P, Min A, Sheiner PA, Guy SR, Schwartz ME, el Younis C, Miller CM. Liver transplantation in a patient with high cold agglutinin titers. Transplantation. 1995 Sep 27; 60(6):622-4.
      View in: PubMed
    159. Mor E, Boccagni P, Thung SN, Sheiner PA, Emre S, Guy SR, Schwartz ME, Miller CM. Backtable resection of a giant cavernous hemangioma in a donor liver. Transplantation. 1995 Sep 27; 60(6):616-7.
      View in: PubMed
    160. Schwartz ME, Sung M, Mor E, Fisher A, Popescu I, Fiel I, Sheiner P, Emre S, Guy S, Miller CM. A multidisciplinary approach to hepatocellular carcinoma in patients with cirrhosis. J Am Coll Surg. 1995 May; 180(5):596-603.
      View in: PubMed
    161. Mor E, Skerrett D, Manzarbeitia C, Sheiner PA, Schwartz ME, Emre S, Thung SN, Miller CM. Successful use of an enhanced immunosuppressive protocol with plasmapheresis for ABO-incompatible mismatched grafts in liver transplant recipients. Transplantation. 1995 Apr 15; 59(7):986-90.
      View in: PubMed
    162. Fisher A, Theise ND, Min A, Mor E, Emre S, Pearl A, Schwartz ME, Miller CM, Sheiner PA. CA19-9 does not predict cholangiocarcinoma in patients with primary sclerosing cholangitis undergoing liver transplantation. Liver Transpl Surg. 1995 Mar; 1(2):94-8.
      View in: PubMed
    163. Curtiss SI, Mor E, Schwartz ME, Sung MW, Hytiroglou P, Thung SN, Sheiner PA, Emre S, Miller CM. A rational approach to the use of hepatic transplantation in the treatment of metastatic neuroendocrine tumors. J Am Coll Surg. 1995 Feb; 180(2):184-7.
      View in: PubMed
    164. Suehiro T, Boros P, Curtiss S, Mor E, Emre S, Sheiner P, Schwartz ME, Miller CM. Perioperative hyaluronic acid levels in orthotopic liver transplant recipient. Transplant Proc. 1995 Feb; 27(1):1261.
      View in: PubMed
    165. Fukuzawa K, Emre S, Senyuz O, Acarli K, Schwartz ME, Miller CM. N-acetylcysteine ameliorates reperfusion injury after warm hepatic ischemia. Transplantation. 1995 Jan 15; 59(1):6-9.
      View in: PubMed
    166. Mor E, Meyers BR, Yagmur O, Kishikawa K, Sheiner PA, Emre S, Schwartz ME, Miller CM. High-dose acyclovir and intravenous immune globulin reduce the incidence of CMV disease after liver transplantation. Transpl Int. 1995; 8(2):152-6.
      View in: PubMed
    167. Sheiner PA, Schwartz ME, Mor E, Schluger LK, Theise N, Kishikawa K, Kolesnikov V, Bodenheimer H, Emre S, Miller CM. Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantation. Hepatology. 1995 Jan; 21(1):30-4.
      View in: PubMed
    168. Katz E, Mor E, Schwartz ME, Theise N, Patel T, Miller CM. Preservation injury in clinical liver transplantation: incidence and effect on rejection and survival. Clin Transplant. 1994 Oct; 8(5):492-6.
      View in: PubMed
    169. Schwartz ME, Sheiner P, Mor E, Sung M, Miller CM. Treatment of hepatoma by liver transplantation. Transplant Sci. 1994 Sep; 4(1):1-3; discussion 3-4.
      View in: PubMed
    170. Jindal RM, Popescu I, Schwartz ME, Emre S, Boccagni P, Miller CM. Diabetogenicity of FK506 versus cyclosporine in liver transplant recipients. Transplantation. 1994 Aug 15; 58(3):370-2.
      View in: PubMed
    171. Mor E, Sheiner PA, Schwartz ME, Emre S, Guy S, Miller CM. Reversal of severe FK506 side effects by conversion to cyclosporine-based immunosuppression. Transplantation. 1994 Aug 15; 58(3):380-2.
      View in: PubMed
    172. Fukuzawa K, Schwartz ME, Acarli K, Katz E, Gabrielson G, Gettes M, Jacobs E, Miller CM. Flushing with autologous blood improves intraoperative hemodynamic stability and early graft function in clinical hepatic transplantation. J Am Coll Surg. 1994 Jun; 178(6):541-7.
      View in: PubMed
    173. Jindal RM, Popescu I, Emre S, Schwartz ME, Boccagni P, Meneses P, Mor E, Sheiner P, Miller CM. Serum lipid changes in liver transplant recipients in a prospective trial of cyclosporine versus FK506. Transplantation. 1994 May 15; 57(9):1395-8.
      View in: PubMed
    174. Schwartz ME. Primary hepatocellular carcinoma: transplant versus resection. Semin Liver Dis. 1994 May; 14(2):135-9.
      View in: PubMed
    175. Mor E, Schwersenz A, Sheiner PA, Emre S, Schwartz ME, Miller CM. Reversal of gastrointestinal toxicity associated with long-term FK506 immunosuppression by conversion to cyclosporine in liver transplant recipients. Transplantation. 1994 Apr 15; 57(7):1130-2.
      View in: PubMed
    176. Sheiner PA, Mor E, Chodoff L, Glabman S, Emre S, Schwartz ME, Miller CM. Acute renal failure associated with the use of ibuprofen in two liver transplant recipients on FK506. Transplantation. 1994 Apr 15; 57(7):1132-3.
      View in: PubMed
    177. Gold JE, Bleiweiss IJ, Goldfarb AB, Bauer JJ, Gelernt IM, Schwartz ME, Reiner MA, Miller CM, Weiss MF, Brower ST, et al. Adoptive cellular therapy of human breast and colorectal tumor targets using ex vivo activated memory T lymphocytes with potentiation by cis-diamminedichloroplatinum(II). J Surg Oncol. 1994 Apr; 55(4):222-8.
      View in: PubMed
    178. Emre S, Schwartz ME, Mor E, Kishikawa K, Yagmur O, Thiese N, Sheiner P, Jindal RM, Chiodini S, Miller CM. Obviation of prereperfusion rinsing and decrease in preservation/reperfusion injury in liver transplantation by portal blood flushing. Transplantation. 1994 Mar 27; 57(6):799-803.
      View in: PubMed
    179. Jindal RM, Train J, Meneses P, Emre S, Schwartz ME, Miller CM. Salvage of liver allograft after hepatic artery thrombosis and hilar biliary structure. Transplantation. 1994 Feb; 57(3):467-9.
      View in: PubMed
    180. Chiodini S, Sung MW, Sheiner P, Mor E, Schwartz ME, Miller CM. Liver transplantation for hepatocellular carcinoma: experience at The Mount Sinai Hospital. Mt Sinai J Med. 1994 Jan; 61(1):37-9.
      View in: PubMed
    181. Mor E, Sheiner PA, Schwartz ME, Emre S, Guy S, Sung M, Bodenheimer H, Berk P, Miller CM. Liver transplantation at Mount Sinai Hospital. Clin Transpl. 1994; 173-80.
      View in: PubMed
    182. Bronster DJ, Emre S, Mor E, Sheiner P, Miller CM, Schwartz ME. Neurologic complications of orthotopic liver transplantation. Mt Sinai J Med. 1994 Jan; 61(1):63-9.
      View in: PubMed
    183. Hoon V, Fasy TM, Kheiri S, Theise N, Lin CS, Klion F, Schwartz M, Miller C, Thung SN. Case report: fatal lymphoproliferative disease seven weeks after liver transplantation. Mt Sinai J Med. 1994 Jan; 61(1):72-6.
      View in: PubMed
    184. Hytiroglou P, Lee R, Sharma K, Theise ND, Schwartz M, Miller C, Thung SN. FK506 versus cyclosporine as primary immunosuppressive agent for orthotopic liver allograft recipients. Histologic and immunopathologic observations. Transplantation. 1993 Dec; 56(6):1389-94.
      View in: PubMed
    185. Sheiner PA, Mor E, Schwartz ME, Miller CM. Use of hepatitis C-positive donors in liver transplantation. Transplant Proc. 1993 Dec; 25(6):3071.
      View in: PubMed
    186. Mor E, Schwartz ME, Sheiner PA, Menesses P, Hytiroglou P, Emre S, Kishikawa K, Chiodini S, Miller CM. Prolonged preservation in University of Wisconsin solution associated with hepatic artery thrombosis after orthotopic liver transplantation. Transplantation. 1993 Dec; 56(6):1399-402.
      View in: PubMed
    187. Mor E, Emre S, Schwartz ME, Sheiner PA, Miller CM. Aneurysm of the celiac artery in a liver allograft. Transplantation. 1993 Dec; 56(6):1548-9.
      View in: PubMed
    188. Fukuzawa K, Schwartz ME, Katz E, Mor E, Emre S, Acarli K, Miller CM. The arcuate ligament syndrome in liver transplantation. Transplantation. 1993 Jul; 56(1):223-4.
      View in: PubMed
    189. Van Ness KE, Theise ND, Schwartz ME, Miller CM. Parasympathetic tone alterations during rat hepatectomy: a cause of preservation/harvest injury? Transplant Proc. 1993 Apr; 25(2):1938-9.
      View in: PubMed
    190. Vivot C, Stump DD, Schwartz ME, Theise ND, Miller CM. N-acetylcysteine attenuates cold ischemia/reperfusion injury in the isolated perfused rat liver. Transplant Proc. 1993 Apr; 25(2):1983-4.
      View in: PubMed
    191. Katz E, Mor E, Patel T, Theise N, Emre S, Schwartz ME, Miller CM. Association between preservation injury and early rejection in clinical liver transplantation: fact or myth? Transplant Proc. 1993 Apr; 25(2):1907-8.
      View in: PubMed
    192. Schwartz ME, Emre S, Mor E, Katz E, Miller CM. Acute portal vein thrombosis: a cause of rapid deterioration of liver function, treatable by thrombectomy and transplantation. Transplant Proc. 1993 Apr; 25(2):1972.
      View in: PubMed
    193. Berner J, Kadian M, Post J, Miller C, Schwartz M, Conn M, Borcich A. Prophylactic recombinant hepatitis B vaccine in patients undergoing orthotopic liver transplantation. Transplant Proc. 1993 Apr; 25(2):1751-2.
      View in: PubMed
    194. Hytiroglou P, Linton P, Klion F, Schwartz M, Miller C, Thung SN. Benign schwannoma of the liver. Arch Pathol Lab Med. 1993 Feb; 117(2):216-8.
      View in: PubMed
    195. Thung SN, Shim KS, Shieh YS, Schwartz M, Theise N, Borcich A, Katz E, Miller C, Gerber MA. Hepatitis C in liver allografts. Arch Pathol Lab Med. 1993 Feb; 117(2):145-9.
      View in: PubMed
    196. Theise ND, Miller F, Worman HJ, Morris P, Schwartz M, Miller C, Thung SN. Biliary cystadenocarcinoma arising in a liver with fibropolycystic disease. Arch Pathol Lab Med. 1993 Feb; 117(2):163-5.
      View in: PubMed
    197. Post J, Miller CM, Schwartz ME, Kadian M. Is it safe to liberalize donor criteria to include those over age 60 and those weighing over 90 kg? Transplant Proc. 1993 Feb; 25(1 Pt 2):1570.
      View in: PubMed
    198. Fukuzawa K, Schwartz ME, Katz E, Mor E, Emre S, Acarli K, Miller CM. An alternative technique for in situ arterial flushing in elderly liver donors with atherosclerotic occlusive disease. Transplantation. 1993 Feb; 55(2):445-7.
      View in: PubMed
    199. Emre S, Mor E, Schwartz ME, Katz E, Acarli K, Fukuzawa K, Miller CM. Liver transplantation in patients beyond age 60. Transplant Proc. 1993 Feb; 25(1 Pt 2):1075-6.
      View in: PubMed
    200. Emre S, Schwartz ME, Katz E, Miller CM. Liver resection under total vascular isolation. Variations on a theme. Ann Surg. 1993 Jan; 217(1):15-9.
      View in: PubMed
    201. Fruchtman SM, Schanzer H, Schwartz ME. The physician's experience: cases and doubts. Mt Sinai J Med. 1993 Jan; 60(1):51-4; discussion 55-8.
      View in: PubMed
    202. Roberti I, Lieberman KV, Manzarbeitia C, Schwartz M, Reisman L, Miller C. Evidence that the systematic analysis of bile cytology permits monitoring of hepatic allograft rejection. Transplantation. 1992 Sep; 54(3):471-4.
      View in: PubMed
    203. Manzarbeitia C, Schwartz ME, Conn M, Miller CM. Simultaneous laparotomy and endoscopy for control of bleeding gastric ulcerations after liver transplantation without enterotomy. Surg Laparosc Endosc. 1992 Jun; 2(2):131-3.
      View in: PubMed
    204. Manzarbeitia C, Schwartz ME, Berman HL, Miller CM. Orthotopic liver transplantation for secondary sclerosing cholangitis associated with hepatic artery embolization. Transplant Proc. 1992 Apr; 24(2):745-7.
      View in: PubMed
    205. Rhodes R, Miller C, Schwartz M. Transplant recipient selection: peacetime vs. wartime triage. Camb Q Healthc Ethics. 1992; 1(4):327-31.
      View in: PubMed
    206. Kahn H, Manzarbeitia C, Theise N, Schwartz M, Miller C, Thung SN. Danazol-induced hepatocellular adenomas. A case report and review of the literature. Arch Pathol Lab Med. 1991 Oct; 115(10):1054-7.
      View in: PubMed
    207. Manzarbeitia C, Schwartz ME, Train JS, Miller CM. Accessory right hepatic duct stricture following liver transplantation. Transplantation. 1991 Sep; 52(3):556-8.
      View in: PubMed
    208. Linton PL, Ahn WS, Schwartz ME, Miller CM, Thung SN. Angiomyolipoma of the liver: immunohistochemical study of a case. Liver. 1991 Jun; 11(3):158-61.
      View in: PubMed
    209. Schwartz ME, Schanzer H, Miller CM. Use of the superficial femoral vein as a replacement for large veins. J Vasc Surg. 1991 Mar; 13(3):460-1.
      View in: PubMed
    210. Schwartz ME, Nishizaki T, Thung SN, Manzarbeitia C, Maharajh A, Gordon R, Miller CM. Initial flush solution for donor liver procurement: lactated Ringers' or UW solution? A randomized, prospective trial. Transplant Proc. 1991 Feb; 23(1 Pt 2):1554-6.
      View in: PubMed
    211. Miller CM, Schwartz ME, Nishizaki T. Combined hepatic and vena caval resection with autogenous caval graft replacement. Arch Surg. 1991 Jan; 126(1):106-8.
      View in: PubMed
    212. Schwartz ME, Harrington EB, Harrington M, Einhorn TA, Haimov M. Above-knee amputation in patients with prior hip surgery: a caveat. J Vasc Surg. 1990 Mar; 11(3):480-1.
      View in: PubMed
    213. Miller CM, Teodorescu V, Harrington M, Harrington EB, Schwartz ME, Ambrosina G, Kadian M, Sampson J. Regional procurement and export of hepatic allografts for transplantation. Mt Sinai J Med. 1990 Mar; 57(2):93-6.
      View in: PubMed
    214. Harrington ME, Schwartz ME, Sanborn TA, Mitty HA, Miller CA, McGinnis K, Harrington EB. Expanded indications for laser-assisted balloon angioplasty in peripheral arterial disease. J Vasc Surg. 1990 Jan; 11(1):146-54; discussion 154-5.
      View in: PubMed
    215. Semashko DC, Schwartz ME, Kaynan A, Harrington EB. Arteriovenous fistula following punch-graft hair transplantation. J Dermatol Surg Oncol. 1989 Jul; 15(7):754-5.
      View in: PubMed
    216. Schwartz ME, Harrington EB, Schanzer H. Wound complications after in situ bypass. J Vasc Surg. 1988 Jun; 7(6):802-7.
      View in: PubMed
    217. Schanzer H, Schwartz M, Harrington E, Haimov M. Treatment of ischemia due to "steal" by arteriovenous fistula with distal artery ligation and revascularization. J Vasc Surg. 1988 Jun; 7(6):770-3.
      View in: PubMed
    218. Schwartz ME, Harrington EB, Rand JH. Unusual venous thrombosis associated with protein C deficiency. J Vasc Surg. 1988 Mar; 7(3):443-5.
      View in: PubMed
    Schwartz's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts
    _
    Co-Authors
    _
    Similar People
    _
    Same Department
     
    Mount Sinai Profiles is managed by Conduits - The Institutes for Translational Sciences at Icahn School of Medicine, supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health through Grant Number UL1TR000067